Top Markets
#1 Akedo Akedo +146.29%
#2 TENDIES TENDIES +96.27%
#3 Threshold Network Threshold Network +47.05%
#4 Verus Coin Verus Coin +43.84%
#5 Mubarak Mubarak +27.69%
#6 Bitway Bitway +26.92%
#7 MultiversX MultiversX +23.94%
#8 Palladium Network Palladium Network +22.69%
#9 Cash Cat Cash Cat +22.59%
#10 aelf aelf +19.17%
Coin of the day
Akedo Akedo
Ayarlar
Dil
TüRKçE
Para birimi
USD
Tema
Shukra Pharmaceuticals Limited Shukra Pharmaceuticals Limited

Shukra Pharmaceuticals Limited

SHUKRAPHAR
Hisse Senetlerindeki Sıralama #17792
Shukra Pharmaceuticals Limited is a prominent company engaged in the... Shukra Pharmaceuticals Limited is a prominent company engaged in the manufacturing and global distribution of pharmaceutical products. Their comprehensive product line addresses a broad spectrum of medical conditions, encompassing anti-infective medications (such as antibiotics, macrolides, quinolones, antivirals, antifungals, antimalarials, antiprotozoals, and anti-helminthics), central nervous system drugs (including sedatives, tranquilizers, antidepressants, and anti-manic agents), gastrointestinal treatments (like anti-emetics and anti-ulcer drugs), cardiovascular remedies (beta-blockers, diuretics), pain and inflammation management (analgesics, muscle relaxants, corticosteroids), anti-tuberculosis drugs, vitamin supplements, anti-allergy medications, and therapies for metabolic imbalances such as hyper- and hypoglycemia. The company was established on March 4, 1993, and its primary operations are directed from its headquarters in Ahmedabad, India.
Hisse Fiyatı
$0.51647906
Piyasa Değeri
$226.16M
Değişim (1 gün)
5.29%
Değişim (1 yıl)
66.66%
Ülke
IN
Ticaret Shukra Pharmaceuticals Limited (SHUKRAPHAR)

Kategori

Healthcare
Shukra Pharmaceuticals Limited (SHUKRAPHAR) için gelir
Sep 2026 itibarıyla gelir TTM: 0
Shukra Pharmaceuticals Limited şirketinin en son finansal raporlarına göre, mevcut geliri (TTM) 0'dir. 2026 yılında şirketin geliri 0 önceki yıla eşit 2026 yılındaki 0 gelirine göre. Gelir, bir şirketin mal veya hizmet satışından elde ettiği toplam tutardır. Kazançtan farklı olarak, hiçbir gider düşülmez.
Shukra Pharmaceuticals Limited için 2026 ile 2026 arasındaki gelir geçmişi
Her yılın sonunda gelir
Yıl Gelir Değiştir
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakiplerin geliri
Şirket Gelir Gelir Farkı Ülke
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $2.54B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Sino Biopharmaceutical Limited Sino Biopharmaceutical Limited
Sino Biopharmaceutical Limited
1177.HK
 $4.88B -
HK